<DOC>
	<DOC>NCT02251860</DOC>
	<brief_summary>ARATA is a prospective, non-interventional, multi-center, observational study in Germany to evaluate the long-term effectiveness and tolerability of subcutaneously administered RoActemra/Actemra (tocilizumab) in patients with rheumatoid arthritis in daily clinical practice. Participants will be followed over an observation period of up to 2 years after the initial injection.</brief_summary>
	<brief_title>An Observational Study to Evaluate the Long-Term Effectiveness and Tolerability of RoActemra®/Actemra® Administered Subcutaneously in Patients With Rheumatoid Arthritis in Everyday Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>Aged &gt;/= 18 years Informed consent Treatment naive to RoActemra/Actemra (tocilizumab) Participation in any interventional clinical trial in rheumatoid arthritis at the time of enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>